Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1

Interventions

pembrolizumab 69Nivolumab 57Ipilimumab 36Specimen Handling 32Magnetic Resonance Spectroscopy 25Cyclophosphamide 22Biopsy 18cemiplimab 14fludarabine 13relatlimab 11binimetinib 11Opdualag 11CTLA-4 Antigen 11trametinib 10fludarabine phosphate 10Radiosurgery 10avelumab 9lifileucel 8dabrafenib 8Radiotherapy 8atezolizumab 7aldesleukin 7Paclitaxel 7Blood Specimen Collection 7encorafenib 6X-Rays 6Standard of Care 6Interleukin-2 6Immunoglobulin G 6HhAntag691 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vitamin D × Dermatologic × 90 days × Clear all
NCT07241585 2026-03-17

Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)

Case Comprehensive Cancer Center

Phase NA Not yet recruiting
54 enrolled
Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡